Published in J Virol on September 01, 1996
Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev (2008) 1.93
Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther (2005) 1.61
Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. J Virol (2006) 1.41
Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol Med (1997) 1.35
Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc Natl Acad Sci U S A (2000) 1.16
Transcriptional Targeting in Cancer Gene Therapy. J Biomed Biotechnol (2003) 1.03
A conditional self-inactivating retrovirus vector that uses a tetracycline-responsive expression system. J Virol (1997) 1.01
Regulatable gene expression systems for gene therapy. Curr Gene Ther (2006) 0.92
Establishment of a doxycycline-regulated cell line with inducible, doubly-stable expression of the wild-type p53 gene from p53-deleted hepatocellular carcinoma cells. Cancer Cell Int (2005) 0.85
Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities. J Mol Genet Med (2006) 0.85
Doxycycline regulation in a single retroviral vector by an autoregulatory loop facilitates controlled gene expression in liver cells. Nucleic Acids Res (2004) 0.84
Doxycycline-regulated 3T3-L1 preadipocyte cell line with inducible, stable expression of adenoviral E4orf1 gene: a cell model to study insulin-independent glucose disposal. PLoS One (2013) 0.82
Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics. BMC Mol Biol (2007) 0.82
Construction and application of an inducible system for homogenous expression levels in bulk cell lines. PLoS One (2009) 0.79
Current status of transcriptional regulation systems. Cytotechnology (2006) 0.79
Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivator. BMC Biotechnol (2013) 0.77
Regulated multicistronic expression technology for mammalian metabolic engineering. Cytotechnology (1998) 0.77
Retroviral vectors. Mol Pathol (2000) 0.76
In Vivo Imaging of Local Gene Expression Induced by Magnetic Hyperthermia. Genes (Basel) (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A (1992) 35.45
Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell (1980) 17.55
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A (1993) 9.17
Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev (1988) 8.82
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol (1994) 7.40
Negative effect of the transcriptional activator GAL4. Nature (1988) 7.15
Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J (1986) 6.08
Activators and targets. Nature (1990) 5.89
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A (1994) 5.71
Transcriptional interference in avian retroviruses--implications for the promoter insertion model of leukaemogenesis. Nature (1984) 5.26
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A (1994) 4.86
A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells. Anal Biochem (1986) 4.60
Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (1984) 4.29
A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci U S A (1995) 3.80
Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequences. Nature (1985) 2.58
A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside. Proc Natl Acad Sci U S A (1991) 2.35
A regulatory system for use in gene transfer. Proc Natl Acad Sci U S A (1994) 2.22
A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science (1989) 1.99
Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol (1996) 1.82
Regulation of protein activities by fusion to steroid binding domains. Methods Cell Biol (1994) 1.43
The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem (1995) 1.20
The nucleotide sequence of bacteriophage phiX174. J Mol Biol (1978) 13.55
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A (1993) 9.17
Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J Mol Biol (1981) 7.94
Partial nucleotide sequence of the 300-nucleotide interspersed repeated human DNA sequences. Nature (1980) 7.92
Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. Proc Natl Acad Sci U S A (1983) 5.50
Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol (1994) 5.17
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A (1994) 4.86
Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (1988) 4.54
Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43
The nucleotide sequence and genome organization of the polyoma early region: extensive nucleotide and amino acid homology with SV40. Cell (1979) 4.23
Base-specific reactions useful for DNA sequencing: methylene blue--sensitized photooxidation of guanine and osmium tetraoxide modification of thymine. Nucleic Acids Res (1978) 4.20
Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells. Cell (1981) 3.61
Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc Natl Acad Sci U S A (1984) 3.53
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 3.49
A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT. Proc Natl Acad Sci U S A (1983) 3.31
Amino acid sequence homology between polyoma and SV40 tumour antigens deduced from nucleotide sequences. Nature (1978) 3.11
Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol (1991) 3.03
Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of beta-lactamase in Pseudomonas aeruginosa and Escherichia coli. J Bacteriol (1987) 2.86
Expression of a retrovirus encoding human HPRT in mice. Science (1984) 2.48
Nucleotide sequence and genetic organization of the polyoma late region: features common to the polyoma early region and SV40. Cell (1979) 2.44
Rapid concentration and purification of polyoma virus and SV40 with polyethylene glycol. Virology (1970) 2.37
The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem (1998) 2.35
A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke (1986) 2.34
Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature (1986) 2.32
Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci U S A (1988) 2.22
Nucleotide sequence studies of polyoma DNA. The Hpa II 3/5 junction to the Hpa II 4/Hae III 18 junction, encoding the origin of DNA replication and the 5' end of the early region. J Biol Chem (1978) 2.19
Analysis of transcription of the human Alu family ubiquitous repeating element by eukaryotic RNA polymerase III. Nucleic Acids Res (1981) 2.18
Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Science (1994) 2.16
Hirayama disease: MR diagnosis. AJNR Am J Neuroradiol (1998) 2.14
Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. Virology (1989) 1.97
Gene expression from transcriptionally disabled retroviral vectors. Proc Natl Acad Sci U S A (1987) 1.89
Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res (1994) 1.84
Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol (1992) 1.79
Gene therapy for human genetic disease? Science (1972) 1.79
Nucleotide sequences at the termini of phi 29 DNA. Proc Natl Acad Sci U S A (1981) 1.76
The organization of the human HPRT gene. Nucleic Acids Res (1986) 1.75
Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA. J Virol (1984) 1.73
Two improved promoter sequences for the beta-lactamase expression arising from a single base-pair substitution. Nucleic Acids Res (1984) 1.72
Structural roles of polyoma virus proteins. J Virol (1972) 1.67
The nucleotide sequence and restriction enzyme sites of the polyoma genome. Nucleic Acids Res (1980) 1.67
Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene. Nucleic Acids Res (1983) 1.63
Variable stability of a selectable provirus after retroviral vector gene transfer into human cells. Mol Cell Biol (1986) 1.62
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 1.58
In vitro reassembly of shell-like particles from disrupted polyoma virus. Proc Natl Acad Sci U S A (1971) 1.58
Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr (1998) 1.57
Thoracic disc herniation mimicking acute lumbar disc disease. Spine (Phila Pa 1976) (1999) 1.54
Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin Cancer Res (1999) 1.54
Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line. Endocrinology (1996) 1.49
Regulation of hepatitis B virus gene expression by its two enhancers. Proc Natl Acad Sci U S A (1992) 1.45
S-phase-specific regulation by deletion mutants of the human thymidine kinase promoter. Proc Natl Acad Sci U S A (1989) 1.45
Hypoplasia of the internal carotid artery with intercavernous anastomosis. Neuroradiology (1998) 1.43
Isolation of a herpes simplex virus type 1 mutant deleted for the essential UL42 gene and characterization of its null phenotype. J Virol (1991) 1.43
Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science (1988) 1.42
Retroviral vector-mediated gene transfer into human hematopoietic progenitor cells. Science (1985) 1.39
Relapsing bacterial meningitis in adults. QJM (1994) 1.38
Epstein-Barr virus-associated thymidine kinase. J Virol (1978) 1.38
Immunoglobulin E (IgE) and IgE-containing cells in human gastrointestinal fluids and tissues. Clin Exp Immunol (1975) 1.36
Immediate restoration of an immediate single-tooth implant. Aust Dent J (2002) 1.36
Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J Virol (1999) 1.32
Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci U S A (1987) 1.31
Long-term transgene expression from genetically modified hepatocytes grafted to the rat liver. New Biol (1992) 1.28
Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol Cell Biol (2000) 1.28
Molecular cloning of a cDNA for a human ADP/ATP carrier which is growth-regulated. J Biol Chem (1987) 1.27
Nucleotide sequence comparisons of plasmids pHD131, pJB1, pFA3, and pFA7 and beta-lactamase expression in Escherichia coli, Haemophilus influenzae, and Neisseria gonorrhoeae. J Bacteriol (1987) 1.27
Nucleotide sequence at polyoma VP1 mRNA splice sites. J Virol (1981) 1.27
In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein. J Virol (1998) 1.26
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci (1994) 1.22
Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proc Natl Acad Sci U S A (1996) 1.21
Cystinosis. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med (1968) 1.20
Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol Ther (2001) 1.20
Rapid nucleotide sequencing of DNA. Am J Hum Genet (1979) 1.19
Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem (1995) 1.17
Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents. Proc Natl Acad Sci U S A (1997) 1.15
Genetic economy of polyoma virus: capsid proteins are cleavage products of same viral gene. Proc Natl Acad Sci U S A (1974) 1.15
Efficient gene expression in mammalian cells from a dicistronic transcriptional unit in an improved retroviral vector. Gene (1991) 1.14
Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain (1999) 1.11
Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele. Am J Psychiatry (1999) 1.11
Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1989) 1.11
Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J Virol (1998) 1.10
Klebsiella meningitis in Taiwan: an overview. Epidemiol Infect (1997) 1.09
Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J (2005) 1.07
Prenatal diagnosis of genetic disease. Sci Am (1971) 1.07
Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience (1993) 1.07
Dose-related analgesic effects of flupirtine. Br J Clin Pharmacol (1991) 1.07
Prognosis of deeply comatose patients on ventilators. J Neurol Neurosurg Psychiatry (1995) 1.06
Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector. J Biol Chem (1984) 1.05